T1	Participants 509 574	women with equivocal (ASCUS) or mildly abnormal (LSIL) Pap tests.
T2	Participants 619 628	608 women
T3	Participants 635 697	histopathologic diagnosis of CIN3 and PCR-based HPV genotyping
T4	Participants 892 922	608 women diagnosed with CIN3,